QT Imaging Schedules Virtual 2025 Annual Meeting of Stockholders for August 19

NOVATO, Calif. — The healthcare technology sector is buzzing with anticipation as QT Imaging Holdings, Inc. (OTCQB: QTIH), announces its 2025 Annual Meeting of Stockholders. The event is slated for Tuesday, August 19, 2025, at 1:00 p.m. EDT (10:00 a.m. PDT), and will be conducted virtually. Shareholders of record as of the close of business on July 16, 2025, will be eligible to cast their votes, a crucial step in shaping the company’s future direction.

For those gearing up to participate, comprehensive details regarding the virtual meeting webcast and the necessary instructions to join will be readily available. These can be found within the definitive proxy statement, which will be filed with the Securities and Exchange Commission. Investors can also access this information on the “Investors” section of QT Imaging’s website at www.qtimaging.com.

About QT Imaging Holdings, Inc.

QT Imaging Holdings, Inc. stands at the forefront of medical device innovation, dedicated to the research, development, and commercialization of cutting-edge body imaging systems. Leveraging the power of low-frequency sound waves, the company is strategically focused on enhancing global health outcomes. Their core philosophy centers on the critical role of medical imaging in disease detection, diagnosis, and treatment, advocating for solutions that are not only safe and affordable but also patient-centric and widely accessible. QT Imaging’s pioneering work includes its advanced Breast Acoustic CT™ technology, a key trademark of an affiliate of the company.

Forward-Looking Statements

This announcement includes forward-looking statements, as defined by securities laws, that reflect QT Imaging’s current expectations and beliefs. These statements, often identified by terms like “will” and “expect,” involve inherent risks and uncertainties. Consequently, actual results could diverge significantly from these projections. Such risks encompass a range of factors, including the research outcomes associated with the QT Imaging Breast Acoustic CT Scanner, the company’s ability to effectively market and deploy this technology, potential expansion into new product areas, the successful commercialization of its innovations, unforeseen challenges in bringing products to market, industry trends and market volatility, shifts in customer demand, supplier unpredictability, the ability to attract and retain skilled personnel, and the scalability of product sales. Investors are encouraged to review the “Risk Factors” section and other disclosures within QT Imaging Holdings’ filings with the SEC for a more comprehensive understanding of these potential challenges. QT Imaging Holdings does not undertake any obligation to update these forward-looking statements, which are based on information available as of the announcement date.

QT Imaging Schedules Virtual 2025 Annual Meeting of Stockholders for August 19